Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss

Traumatic Amputation of Lower Extremity Clinical Trial

Official title:

Improving Mobility and Function Following Transfemoral Amputation: A Novel Approach to Reverse Volumetric Muscle Loss

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05929508
• Other study ID #: 2023-0250
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2024
• Est. completion date: December 31, 2027

Study information

• Verified date: May 2024
• Source: University of Illinois at Chicago
• Contact: Lindsay Slater
• Phone: 3123558965
• Email: slaterlv[@]uic.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the relationship between thigh strength and walking ability and assess if using a blood pressure cuff on the leg improves strength and walking performance.

Description:

One in every 190 Americans is currently living with the loss of a limb. Following lower limb amputation (LLA), individuals have double the risk of knee and hip pain, a high prevalence of osteoarthritis in the intact limb with a prevalence ratio of 3.3 compared to those without amputation, and up to 90% experience severe back pain. The long-term consequences of LLA may be mitigated through regular use of prosthesis and physical activity, which would also increase the likelihood of returning to work and reintegration of Service Members (SMs) and younger Veterans. Clinicians and researchers often focus on the prosthetic fit to improve outcomes, however just providing a prosthetic, even the most advanced prosthetic, is not enough to restore function. Interventions targeting physical capabilities to complement device intervention may be key to improving outcomes in individuals with LLA. Along with increased orthopaedic risks, individuals with traumatic LLA also have an increased risk of cardiovascular events compared to the general population. SMs with traumatic unilateral transfemoral amputation have a 1.58 times greater risk of death from cardiovascular causes and their relative risk of aortic aneurysm is 5.1 times greater than Veterans without amputation. There is evidence to suggest that individuals with LLA have increased peripheral vascular resistance following amputation, leading to vasoconstriction and increased blood pressure. Reduced arterial function (i.e. increased arterial stiffness) is an important measure in those with LLA because it predicts mortality, heart failure, and cardiovascular events. In addition, improved arterial function improves perfusion to muscle and reduces fatigue during exertion. Therefore, strategies that reduce arterial stiffness and vascular resistance in individuals with LLA are important to improve mortality and quality of life for SMs and Veterans. Therefore, we propose implementing ischemic preconditioning (IC) as a novel intervention to strengthen and hypertrophy leg muscles and increase arterial function for improving outcomes after amputation.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 31, 2027
• Est. primary completion date: June 1, 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• At least 18 years old
• History of lower limb unilateral transfemoral amputation.
• At least two years post lower limb amputation
• Able to ambulate independently without the use of aids (i.e., walking cane).
• Able to walk at least 10 minutes continuously without stopping.
• Has a safe residuum with no open wounds on either the residual or intact limb.
• Has a prosthetic limb with materials that are sound and safe to withstand the mobility requirements of the study.

Exclusion Criteria:

• Younger than 18 years old.
• Inability to give informed consent.
• Neurological disorder that affects gait.
• Participants with significant metal (greater than one orthopaedic screw) in either the residual limb or the sound/intact limb
• Participants who begin taking medications or change dosage of medications that could affect gait, balance, and cardiovascular function during the course of the study.
• Currently pregnant (or intend to become pregnant while participating in study).
• History of any condition where fatiguing contractions or resisted leg contractions are contraindicated.
• Blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg).
• History of uncontrolled hypertension.
• History of heart failure.
• Head injury within the previous 6 months.
• Seizure disorder.
• History of vascular disease.
• History of thrombosis.
• History of sickle cell trait.
• History of genetic disease

Related Conditions & MeSH terms

• Amputation, Traumatic
• Traumatic Amputation of Lower Extremity

Intervention

Other:
• Ischemic Preconditioning
A blood pressure cuff will be placed on the thigh of the intact/sound limb to restrict blood flow to the lower extremity for 5 minutes and then deflated for 5 minutes to allow for normal blood flow on a cycle for 50 minutes (5 times).

Locations

Country	Name	City	State
United States	UIC Physical Therapy Faculty Practice	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Illinois at Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Strength	Comparing leg strength before and after intervention	through study completion, an average of 6 weeks
Primary	Gait	Comparing leg strength before and after intervention	through study completion, an average of 6 weeks
Primary	Metabolics	Comparing leg strength before and after intervention	through study completion, an average of 6 weeks
Primary	Daily Steps/Activity	Comparing leg strength before and after intervention	through study completion, an average of 6 weeks
Primary	Arterial Stiffness	Comparing leg strength before and after intervention	through study completion, an average of 6 weeks